Search

everythinglearnresearchcommunity

for

Search:↓

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

A specific gene change in APCDD1 increases the risk of hair loss.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Enzymes that change arginine to citrulline are important for skin barrier and hair formation, and their malfunction can lead to skin conditions and hair disorders.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Upadacitinib effectively treats pyoderma gangrenosum.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Mice with human gene experienced hair loss when treated with DHT.

Genomic approach finds new possible treatments for hair loss.

Immune activities and specific genes are important in male pattern baldness.

A certain gene variation can affect protein production and is linked to male pattern baldness.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Targeting specific T cells may help treat alopecia areata.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Three genes in Arabidopsis are important for plant growth and development by affecting sugar attachment to proteins.